Akili Interactive Receives $11,900,000 Series B Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0ed598b8-b91f-41ab-b592-bc798ae3e1c8 - Date
7/20/2016 - Company Name
Akili Interactive - Mailing Address
501 Boylston Street Boston, MA 02116 USA - Company Description
Transforming healthcare with clinically-validated digital medicine. - Website
http://www.akiliinteractive.com - Transaction Type
Venture Equity - Transaction Amount
$11,900,000 - Transaction Round
Series B - Proceeds Purposes
Akili will use the funds to support and expand clinical development of its clinical-stage products into new areas, with an expanded focus on neurodegeneration, and to build out its commercial infrastructure as Akili nears the market with its late-stage products. - M&A Terms
- Venture Investor
Merck Capital Ventures - Venture Investor
Amgen Ventures
